{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-23-023757","form_type":"8-K","ticker":"WOOF","cik":"0001826470","company_name":"Petco Health & Wellness Company, Inc.","filed_at":"2023-05-24T23:59:59+00:00","discovered_at":"2026-05-14T18:03:40.922812+00:00","generated_at":"2026-06-14T16:09:01.622985+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Petco Q1 revenue up 5.4% to $1.56B, net loss $1.9M, reaffirms FY2023 guidance","bullets":["Comparable sales grew 5.1% YoY (18th consecutive quarter); consumables +11.2%, services +25.4%.","Adjusted EPS $0.06 vs $0.14 prior year; adjusted EBITDA $111.0M, down 6.9% YoY.","Net loss of $1.9M ($0.01/sh) vs net income $24.7M ($0.09/sh) prior year, driven by higher interest expense.","Paid down $35M term loan in Q1 and $25M in May; targeting $100M total debt paydown in 2023.","Company reaffirms full year 2023 guidance; remains focused on de-levering balance sheet."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-23-023757","json":"https://secwatch.observer/filing/0000950170-23-023757.json","markdown":"https://secwatch.observer/filing/0000950170-23-023757.md","text":"https://secwatch.observer/filing/0000950170-23-023757.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1826470/000095017023023757/0000950170-23-023757-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1826470/000095017023023757/woof-20230524.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-14T16:09:01.622985+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"32ea4a014d48b818b9901c35be1c953e17cce280","claim":"Petco Health & Wellness Company, Inc. reported first quarter of fiscal 2023 results: revenue $1.56 billion, net income Net loss of $1.9 million, EPS $(0.01) per diluted share. Guidance reaffirmed.","evidence_excerpt":"• Comparable sales grew 5.1 percent year-over-year and 10.2 percent on a two-year basis, resulting in the 18 th consecutive quarter of comparable sales growth • Net revenue of $1.56 billion increased 5.4 percent year-over-year • Net loss of $1.9 million, or $(0.01) per diluted share compared to net income of $24.7 million, or $0.09 per diluted share in the prior","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1826470/000095017023023757/0000950170-23-023757-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"first quarter of fiscal 2023"},{"label":"Revenue","value":"$1.56 billion"},{"label":"Net income","value":"Net loss of $1.9 million"},{"label":"EPS","value":"$(0.01) per diluted share"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"55c32be4826c34af854c13ed506bdf82a512391b","claim":"Petco Health & Wellness Company, Inc. reported the quarter ended April 29, 2023 results: revenue $1.56 billion, net income $1.9 million, EPS $(0.01) per diluted share. Guidance reaffirmed.","evidence_excerpt":"• Comparable sales grew 5.1 percent year-over-year and 10.2 percent on a two-year basis, resulting in the 18 th consecutive quarter of comparable sales growth • Net revenue of $1.56 billion increased 5.4 percent year-over-year • Net loss of $1.9 million, or $(0.01) per diluted share compared to net income of $24.7 million, or $0.09 per diluted share in the prior","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1826470/000095017023023757/0000950170-23-023757-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the quarter ended April 29, 2023"},{"label":"Revenue","value":"$1.56 billion"},{"label":"Net income","value":"$1.9 million"},{"label":"EPS","value":"$(0.01) per diluted share"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}